Cargando…

Berry Dietary Interventions in Metabolic Syndrome: New Insights

Metabolic Syndrome (MetS) is characterized by a group of dysmetabolic conditions, including abdominal obesity, dyslipidemia, glucose intolerance and/or insulin resistance, and hypertension. Generally, MetS is accompanied by an exacerbation of oxidative stress, inflammation, and vascular dysfunction....

Descripción completa

Detalles Bibliográficos
Autores principales: Venturi, Samuele, Marino, Mirko, Cioffi, Iolanda, Martini, Daniela, Del Bo’, Cristian, Perna, Simone, Riso, Patrizia, Klimis-Zacas, Dorothy, Porrini, Marisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142833/
https://www.ncbi.nlm.nih.gov/pubmed/37111125
http://dx.doi.org/10.3390/nu15081906
_version_ 1785033706947215360
author Venturi, Samuele
Marino, Mirko
Cioffi, Iolanda
Martini, Daniela
Del Bo’, Cristian
Perna, Simone
Riso, Patrizia
Klimis-Zacas, Dorothy
Porrini, Marisa
author_facet Venturi, Samuele
Marino, Mirko
Cioffi, Iolanda
Martini, Daniela
Del Bo’, Cristian
Perna, Simone
Riso, Patrizia
Klimis-Zacas, Dorothy
Porrini, Marisa
author_sort Venturi, Samuele
collection PubMed
description Metabolic Syndrome (MetS) is characterized by a group of dysmetabolic conditions, including abdominal obesity, dyslipidemia, glucose intolerance and/or insulin resistance, and hypertension. Generally, MetS is accompanied by an exacerbation of oxidative stress, inflammation, and vascular dysfunction. Increasing evidence suggests that berries and berry bioactives could play a potential role in the prevention and mitigation of the risk factors associated with MetS. The present systematic review summarizes the more recently available evidence deriving from human intervention studies investigating the effect of berries in subjects with at least three out of five MetS parameters. The PubMed, Scopus, and Embase databases were systematically searched from January 2010 until December 2022. A total of 17 human intervention trials met the inclusion criteria. Most of them were focused on blueberry (n = 6), cranberry (n = 3), and chokeberry (n = 3), while very few or none were available for the other berries. If considering MetS features, the main positive effects were related to lipid profile (low and high-density lipoproteins, cholesterol, and triglycerides) following blueberries and chokeberries, while conflicting results were documented for anthropometric parameters, blood pressure, and fasting blood glucose levels. Other markers analyzed within the studies included vascular function, oxidative stress, and inflammation. Here, the main positive effects were related to inflammation with a reduction in interleukin 6 and tumor necrosis factor-alpha following the intake of different berries. In conclusion, although limited, the evidence seems to support a potential role for berries in the modulation of lipid profile and inflammation in subjects with MetS. Furthermore, high-quality intervention trials are mandatory to demonstrate the role of berries in reducing risk factors for MetS and related conditions. In the future, such a demonstration could bring the adoption of berries as a potential dietary strategy to prevent/counteract MetS and related risk factors.
format Online
Article
Text
id pubmed-10142833
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101428332023-04-29 Berry Dietary Interventions in Metabolic Syndrome: New Insights Venturi, Samuele Marino, Mirko Cioffi, Iolanda Martini, Daniela Del Bo’, Cristian Perna, Simone Riso, Patrizia Klimis-Zacas, Dorothy Porrini, Marisa Nutrients Review Metabolic Syndrome (MetS) is characterized by a group of dysmetabolic conditions, including abdominal obesity, dyslipidemia, glucose intolerance and/or insulin resistance, and hypertension. Generally, MetS is accompanied by an exacerbation of oxidative stress, inflammation, and vascular dysfunction. Increasing evidence suggests that berries and berry bioactives could play a potential role in the prevention and mitigation of the risk factors associated with MetS. The present systematic review summarizes the more recently available evidence deriving from human intervention studies investigating the effect of berries in subjects with at least three out of five MetS parameters. The PubMed, Scopus, and Embase databases were systematically searched from January 2010 until December 2022. A total of 17 human intervention trials met the inclusion criteria. Most of them were focused on blueberry (n = 6), cranberry (n = 3), and chokeberry (n = 3), while very few or none were available for the other berries. If considering MetS features, the main positive effects were related to lipid profile (low and high-density lipoproteins, cholesterol, and triglycerides) following blueberries and chokeberries, while conflicting results were documented for anthropometric parameters, blood pressure, and fasting blood glucose levels. Other markers analyzed within the studies included vascular function, oxidative stress, and inflammation. Here, the main positive effects were related to inflammation with a reduction in interleukin 6 and tumor necrosis factor-alpha following the intake of different berries. In conclusion, although limited, the evidence seems to support a potential role for berries in the modulation of lipid profile and inflammation in subjects with MetS. Furthermore, high-quality intervention trials are mandatory to demonstrate the role of berries in reducing risk factors for MetS and related conditions. In the future, such a demonstration could bring the adoption of berries as a potential dietary strategy to prevent/counteract MetS and related risk factors. MDPI 2023-04-14 /pmc/articles/PMC10142833/ /pubmed/37111125 http://dx.doi.org/10.3390/nu15081906 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Venturi, Samuele
Marino, Mirko
Cioffi, Iolanda
Martini, Daniela
Del Bo’, Cristian
Perna, Simone
Riso, Patrizia
Klimis-Zacas, Dorothy
Porrini, Marisa
Berry Dietary Interventions in Metabolic Syndrome: New Insights
title Berry Dietary Interventions in Metabolic Syndrome: New Insights
title_full Berry Dietary Interventions in Metabolic Syndrome: New Insights
title_fullStr Berry Dietary Interventions in Metabolic Syndrome: New Insights
title_full_unstemmed Berry Dietary Interventions in Metabolic Syndrome: New Insights
title_short Berry Dietary Interventions in Metabolic Syndrome: New Insights
title_sort berry dietary interventions in metabolic syndrome: new insights
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142833/
https://www.ncbi.nlm.nih.gov/pubmed/37111125
http://dx.doi.org/10.3390/nu15081906
work_keys_str_mv AT venturisamuele berrydietaryinterventionsinmetabolicsyndromenewinsights
AT marinomirko berrydietaryinterventionsinmetabolicsyndromenewinsights
AT cioffiiolanda berrydietaryinterventionsinmetabolicsyndromenewinsights
AT martinidaniela berrydietaryinterventionsinmetabolicsyndromenewinsights
AT delbocristian berrydietaryinterventionsinmetabolicsyndromenewinsights
AT pernasimone berrydietaryinterventionsinmetabolicsyndromenewinsights
AT risopatrizia berrydietaryinterventionsinmetabolicsyndromenewinsights
AT klimiszacasdorothy berrydietaryinterventionsinmetabolicsyndromenewinsights
AT porrinimarisa berrydietaryinterventionsinmetabolicsyndromenewinsights